Latent, a San Francisco, CA-based provider of an AI platform for medication access, has raised $80 million in a Series A funding round led by Spark Capital and Transformation Capital.
The round also saw participation from Conviction, McKesson Ventures, General Catalyst, and Y Combinator.
The company plans to use the funds to grow its presence in health systems, strengthen its platform that connects hospitals, insurers, pharmacies, and patients, improve reliability and trust in healthcare operations, and expand its team.
Modern medicine has progressed quickly, but the systems that deliver care have not kept up. In the U.S., doctors and patients often agree on a treatment, but in many serious cases, medication is delayed or denied due to paperwork, payer rules and pharmacy coordination. This happens not because the treatment is wrong or unavailable, but because the process between prescription and delivery is slow and manual.
Read More:ReAlta Life Sciences Raises $40M in Funding
Today, healthcare staff spend a lot of time switching between systems, re-entering data, and proving information that already exists in patient records. This complex, high-stakes work involves checking clinical details, insurance rules, and eligibility criteria, and it is mostly done by hand.
Latent is building a Clinical Reasoning Engine that uses AI to automate this process. It connects hospital records, insurance rules, pharmacy systems, and patient communication into one system that can understand clinical data, apply coverage rules, and manage workflows automatically, helping patients get treatment faster—often on the same day.
The company started with prior authorization, one of the most difficult parts of the system, and has already helped more than 2 million patients get faster access to medication. It now works with over 45 health systems, including major institutions like Yale New Haven Health, Mount Sinai, UCSF Health, and UCLA Health, helping reduce denials and improve efficiency across care delivery.
In the future, Latent aims to use its platform to identify when patients need treatment earlier and ensure they stay on it, reducing delays and improving access to care across the healthcare system.
Latent is a place for talented people who believe their responsibility doesn’t stop at diagnosis, but continues until patients actually get the care they need.
About Latent Health
Founded in 2022, by Sriram Somasundaram and Rishabh Jain, Latent Health is an AI platform that helps patients get access to medications faster. It brings clinical intelligence into patient records to help care teams move from diagnosis to treatment more quickly and reliably. The company supports over 2 million patients each year and is used by more than 45 major health systems across the U.S., including Yale New Haven Health, Mount Sinai Health System, UCSF Health, and UCLA Health.
Read More:Pomo Raises $4.5M in Seed Funding
